StreetAlpha.app
Home › Stocks › BHC

Bausch Health Companies Inc. (BHC)

Healthcare
$8.22
▼ −3.97%
LAST CLOSE · NOV 20

Bausch Health develops and sells branded and generic medicines, nonprescription products and aesthetic medical devices. It last closed at $8.22 on Nov 20, down 3.97% on the day. The next earnings report for BHC is expected around Tue, Jan 12, 2027. For the quarter ended Sep 2026, BHC reported EPS of $1.15 on revenue of $2.94B, with revenue up 9.7% from a year ago. Over its last 8 reports the stock moved an average of 10.5% the session after earnings. Over the last 12 months BHC insiders bought $15.6M of stock on the open market and sold $507K, according to SEC Form 4 filings.

AI Auto Pilots
Is BHC in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold BHC.

Key Stats

Last 12 months
Results
Revenue
$11.1B
+10.8% vs a year ago
Net income
−$841.0M
−332.3% vs a year ago
EPS (diluted)
−$2.25
−332.0% vs a year ago
Free cash flow
$1.9B
16.8% margin
Valuation
Market cap
$3.1B
374.3M shares
P/E
–
No P/E while losing money
Price to sales
0.3
Market cap over revenue
Dividend yield
None
No dividend in 12 months
Balance sheet
Cash & equivalents
$2.5B
At Sep 30
Debt
$20.6B
At Sep 30
Shareholder equity
−$1.3B
Shares outstanding
374.3M
At Oct 23
Fiscal year endsDecember
ExchangeNYSE
Financials history
FY2021: $8.4B$8.4BFY2021FY2022: $8.1B$8.1BFY2022FY2023: $8.8B$8.8BFY2023FY2024: $9.6B$9.6BFY2024FY2025: $10.3B$10.3BFY2025

From BHC's SEC filings, latest 10-Q for the period ending Sep 30, 2026 (filed Oct 29). Last 12 months adds up the four latest quarters.

Next report
Jan 12
Estimated date · Time not announced
Reported EPS
$1.15
Quarter ended Sep 2026
Year ago EPS
$0.48
+139.6% on a GAAP basis
Revenue
$2.94B
+9.7% vs a year ago
Estimates and implied move
Consensus forecasts and the move options price in
EPS by quarter (GAAP)
Dec 2024: $0.25Dec '24Mar 2025: -$0.16Mar '25Jun 2025: $0.40Jun '25Sep 2025: $0.48Sep '25Dec 2025: -$0.30Dec '25Mar 2026: -$3.82Mar '26Jun 2026: $0.68Jun '26Sep 2026: $1.15Sep '26Latest $1.15
Revenue by quarter
Dec 2024: $2.56BDec '24Mar 2025: $2.26BMar '25Jun 2025: $2.53BJun '25Sep 2025: $2.68BSep '25Dec 2025: $2.80BDec '25Mar 2026: $2.52BMar '26Jun 2026: $2.85BJun '26Sep 2026: $2.94BSep '26Latest $2.94B
How BHC moved after its last 8 reports
Average move the session after a report ±10.5%
Oct 28, 2026After the close+28.8%
Jul 29, 2026After the close+28.9%
Apr 29, 2026After the close+2.3%
Feb 18, 2026After the close−4.2%
Jan 13, 2026Time not announced+0.1%
Oct 29, 2025After the close+12.0%
Jul 30, 2025After the close−7.8%
Apr 30, 2025After the close0.0%
Close to close, the session after each report, adjusted for splits. Past moves are no guide to the next one.
StreetAlpha's call on BHCStart your 7 day free trial to see StreetAlpha's call before the report, with the options flow, dark pool, history and technical scores behind it.Sign up freeSign in

Analyst Ratings & Price Targets

Analyst Ratings →
AI Starter and AI Pro
Full analyst coverage on BHC
  • Every upgrade, downgrade and initiation as it happens
  • Every price target change, raised or cut
  • Consensus rating with the average, high and low targets
  • Each firm's full rating history on BHC

Technical Analysis

BHC · as of the Nov 20 close · updated each morning
Uptrend

The stock is 2% above its 20 day and 17% above its 50 day average. It is 29% above its 200 day average, so the longer trend is still up. Momentum is neutral (RSI 59). The nearest support is the 20 day average at $8.07, and the nearest resistance the Pivot at $8.30.

Short trendBullish
Long trendBullish
MomentumNeutral
StretchNormal
VolatilityNormal, 4.3%/day
Key levels
$9.0452 week high+10.0%
$8.56Swing high (Nov 9)+4.1%
$8.48Pivot R1+3.2%
$8.30Pivot+1.0%
$8.22Last close
$8.0720 day average−1.8%
$8.04Pivot S1−2.2%
$7.86Swing low (Nov 6)−4.4%
$6.8050 day average−17.3%
$6.30100 day average−23.4%
$5.87200 day average−28.6%
$4.3352 week low−47.3%
Indicators
RSI (14)58.55Middle of its rangeNeutral
MACD0.49Below its signal lineBearish
Stochastic60.5Middle of its rangeNeutral
ADX (14)40.1Strong uptrend
Williams %R-63.5Oversold below −80, overbought above −20Neutral
CCI (20)34.1Oversold below −100, overbought above 100Neutral
Rate of change+0.5%Change over 10 sessionsBullish
ATR (14)$0.36Typical daily range, 4.3% of price
MA 10Below
MA 20Above
MA 50Above
MA 100Above
MA 200Above
What happened before, for BHC

What happened before

See how BHC did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.

November seasonalityHow BHC usually does this month. See Seasonality

Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.

AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.

Seasonality

How BHC has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2018.

Loading…

See the stocks that usually rise in November →

Whale Options Flow

90D
Whale options flow for BHCHow many large options trades hit BHC, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in

See today’s whale options flow across the market →

Dark Pool

30D
Prints
Notional
Largest print
Loading…

BHC Institutional Ownership

Full report →
Fund sentiment · Q3 2026
Bullish
Strongly bearishNeutralStrongly bullish
  • ▲119 buying vs 85 selling
  • ▼Held by funds -3.6 pts
  • ▲Funds holding +12
  • ▲Superinvestors: 5 added, 0 cut
  • ●Put/call not meaningful
Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Funds holdingHeld by funds %
Q3 2026This quarterLast quarterChange
Funds holding232220+5.5%
In funds' top 1045−20.0%
Held by funds59.8%63.4%−3.6 pts
New / increased41 / 7826 / 66+29.3%
Reduced / sold out58 / 2763 / 35−13.3%
Put/call ratio3.832.68+43.0%
Top holders, biggest buyers and sellers, 8 quarters of charts and this season's filings so far.See BHC institutional ownership →

From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.

BHC Insider Trading

All filings →
Insider trading · 12 months
Insiders are net buyers
Bought$15.6M1 buy · 1 insider
Sold$507K4 sales · 3 insiders
100% of the selling was under pre-arranged trading plans.
2026-02 sold $50K2026-03 sold $65K2026-05 sold $133K2026-08 sold $259KDecMarJunSep
BoughtSoldlast 12 months
Trade dateInsiderTypeSharesPriceValue
Aug 19Aimee J. LenarPresident, US PharmaSale plan36,827$7.03$259K
May 19Frank D. LeeDirectorSale plan24,456$5.43$133K
Mar 3Seana CarsonEVP, General CounselSale plan11,276$5.78$65K
Feb 27Seana CarsonEVP, General CounselSale plan8,388$5.95$50K
Nov 25, 2025Paulson & Co. Inc.10% ownerBuy2,500,000$6.25$15.6M
Sep 8, 2025Seana CarsonEVP, General CounselSale plan13,370$7.31$98K
Every insider buy and sale for BHC over 2 years, with a link to each SEC filing. AI Pro members can get an alert the moment an insider trades.See BHC insider trades →

From SEC Form 4 filings by BHC's officers, directors and 10% owners. Open market buys and sales only; option exercises, gifts, awards and tax withholding are left out. Not investment advice.

AI Auto Pilots

Paper trading

StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether BHC is in one of them and how their past BHC trades turned out.

BHC in the AI portfolios
Loading…

BHC News Tone and Price

Loading…

Macro & Market News

All StreetAlpha news →

StreetAlpha hasn't covered BHC in an article yet. Here's the latest on the wider market.

BHC in the news

BHC Congress Trades

All congress trades →
Trades, 12 months
0
Buys
0
Sells
0
People
0
Last filed Oct 7
Who traded BHC · since 2020
Latest 3 filings
$1K – $15KTraded Aug 27, 2020Filed Oct 7, 2020
$1K – $15KTraded Feb 24, 2020Filed Apr 28, 2020
$1K – $15KTraded Jan 6, 2020Filed Feb 25, 2020
PersonTypeAmountTradedFiledDelay
Susie LeeD · NVSell$1K – $15KAug 27, 2020Oct 7, 202041 d
Susie LeeD · NVBuy$1K – $15KFeb 24, 2020Apr 28, 202064 d
Susie LeeD · NVBuy$1K – $15KJan 6, 2020Feb 25, 202050 d

From official House and Senate disclosure reports, filed up to 45 days after the trade and shown in dollar ranges. Not investment advice. Use limited by 5 U.S.C. 13107. About this data

About Bausch Health Companies

Bausch Health is a specialty pharmaceutical and medical device company based in Quebec, Canada. It develops, makes and sells branded and generic prescription medicines, nonprescription products and aesthetic medical devices. Its main treatment areas include gastroenterology, hepatology, neurology and dermatology, and its products are sold in the United States and in many other countries across Asia, Europe, Latin America, Africa and the Middle East.

Headquarters
Quebec, Quebec, Canada